Intec Readying for New Phase 3 Accordion Pill Study in Parkinson’s

Intec Readying for New Phase 3 Accordion Pill Study in Parkinson’s
Intec Pharma and its manufacturing partner, Lohman Therapie-Systeme (LTS) have shown an ability to manufacture the Accordion Pill Carbidopa/Levodopa (AP-CD/LD), an investigational Parkinson’s therapy, at a commercial scale, and are advancing with the production of stability lots expected to bring it into a new Phase 3 trial. Meanwhile, Intec is looking for partners for the late-stage development and commercialization of AP-CD/LD. “Our partnering ... read more
Source: Parkinson’s News TodayPublished on 2020-05-18By Ines Martins, PhD